Valeo Financial Advisors, LLC Akebia Therapeutics, Inc. Transaction History

Valeo Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$2.22 - $3.78 $18,303 - $31,166	-8,245 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$6.67 - $13.58 $5,336 - $10,864	800 Added 10.75%	8,245 $112,000
Q1 2020 Apr 13, 2020	BUY	$4.1 - $10.24 $7,154 - $17,868	1,745 Added 30.61%	7,445 $52,000
Q1 2019 Apr 12, 2019	BUY	$5.41 - $8.73 $6,762 - $10,912	1,250 Added 28.09%	5,700 $47,000
Q2 2018 Aug 14, 2018	BUY	$9.15 - $11.34 $36,142 - $44,793	3,950 Added 790.0%	4,450 $35,000
Q4 2017 Feb 09, 2018	BUY	$14.24 - $19.59 $7,120 - $9,795	500	500 $7,000

121

54.8M

291K

179K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $346M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.